Similarly to the Kouchaki et al. (2017) study, the authors reported an improvement in EDSS, depression and general health questionnaires and a decrease in levels of CRP, MDA, and IL-6, and with increased concentration of NO and IL-10. The gene discussed is IL10; the disease is depressive symptom measurement.